Drug intelligence / Profile preview

Zhi Chuan Capsule

Development stage: Phase 2
Lead developer: Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Zhi Chuan Capsule is a Traditional Chinese Medicine (TCM) formulation developed by the Shanghai University of Traditional Chinese Medicine for the treatment of bronchial asthma. It is typically evaluated within the framework of TCM syndrome differentiation, specifically targeting patients whose asthma symptoms align with particular TCM patterns. As a botanical product, it is composed of multiple herbal ingredients intended to alleviate airway obstruction, reduce inflammation, and manage wheezing. In clinical research, it has been studied in Phase 2 trials to assess its efficacy and safety compared to other TCM mixtures and placebos in community hospital settings.

Other names: Zhi ChuanZhi Chuan Capsule

Beyond the preview

Go deeper on Zhi Chuan Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhi Chuan Capsule.

Explore the full profile